Response to Comment on: Hasselgren K, et al ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO. Ann Surg. 2021;273(3):442-448

MLA

Hasselgren, Kristina, et al. Response to Comment on: Hasselgren K, et Al ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO. Ann Surg. 2021;273(3):442-448. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1349066176&authtype=sso&custid=ns315887.

APA

Hasselgren, K., Rosok, B. I., Larsen, P. N., Sparrelid, E., Lindell, G., Schultz, N. A., Bjornbeth, B. A., Isaksson, B., Lindhoff Larsson, A., Rizell, M., Björnsson, B., & Sandström, P. (2022). Response to Comment on: Hasselgren K, et al ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO. Ann Surg. 2021;273(3):442-448.

Chicago

Hasselgren, Kristina, Bard I. Rosok, Peter N. Larsen, Ernesto Sparrelid, Gert Lindell, Nicolai A. Schultz, Bjorn A. Bjornbeth, et al. 2022. “Response to Comment on: Hasselgren K, et Al ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO. Ann Surg. 2021;273(3):442-448.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1349066176&authtype=sso&custid=ns315887.